drugset / Trial / NCT01653314
Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers
RandomizedCrossoverDouble-blindBasic science
Summary
The purpose of this Study is to Assess Safety and Pharmacokinetics of megavec 400 mg (Imatinib mesylate) under Fasted Conditions in Healthy Male Subjects.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imatinib | Small molecule | 400 mg | — |
Indications
No indication recorded.